Peptide Science
GHK-Cu: real skin science, overstated conclusions
What copper peptide research does and does not tell us about aging dogs.
GHK-Cu is a three-amino-acid peptide that binds copper. It occurs naturally in plasma and is widely used in topical cosmetic formulations.
It is one of the clearest examples of a real finding being inflated: broad changes in gene expression are frequently marketed as whole-body rejuvenation.
Collagen
Cell and tissue studies describe increased collagen synthesis. Collagen is central to skin, tendon and cartilage structure, so the interest is legitimate.
Skin
Skin is where this compound has the most supportive research, largely in cosmetic and wound contexts. Topical gels and cosmetic formulations are distinct from injectable exposure, and evidence for one route cannot establish the other.
Hot spots and chronic itching are reasons GHK-Cu is discussed in dog-owner circles, but we found no controlled canine trial showing it treats either condition.
Connective tissue & tissue remodeling
Remodelling research describes how repair tissue is reorganised over time, including effects on scarring. Most of it is laboratory work.
Wound healing
Wound models are the strongest thread. Acute healing and slow aging are different questions with different timescales.
Blood vessel formation
Angiogenesis appears here too, as in most repair-signalling research.
The level of canine evidence
One small controlled canine wound study exists, but we found no canine healthspan or lifespan research supporting this compound.
That canine study measured acute pad-wound healing and collagen deposition. It cannot answer whether GHK-Cu changes whole-body aging.
What would need to be studied in dogs
Whether anything topical reaches a systemic target relevant to aging.
What the copper safety margin looks like in dogs, including breeds prone to accumulation.
Whether gene-expression changes are durable or transient.
Actual studies
- Controlled canine wound studyPubMed PMID 8669775
Effect of locally injected medications on healing of pad wounds in dogs
Swaim SF, Vaughn DM, Kincaid SA, et al. AJVR. 1996;57(3):394–399.
- Study design
- Controlled experimental study of full-thickness paw-pad wounds with measurements through day 21.
- Population
- Twelve mature English Pointers.
- Intervention
- Local tripeptide-copper complex compared with an immunostimulant and saline.
- What was measured
- Wound area, healing rate, hydroxyproline content and type-I versus type-III collagen in biopsies.
- What the paper reported
- The tripeptide-copper group had greater type-I collagen content than controls at day 14. The abstract describes positive healing effects, while the immunostimulant produced the strongest early healing-rate effect.
- Important limitations
- Small single-breed experimental study, short follow-up and no blinding stated. It studied an acute wound—not aging, mobility, healthspan or lifespan.
- Non-canine ischemic wound modelPubMed PMID 14648529
The effect of topical tripeptide-copper complex on healing of ischemic open wounds
Canapp SO Jr, Farese JP, Schultz GS, et al. Veterinary Surgery. 2003;32(6):515–523.
- Study design
- Three-arm controlled experiment comparing topical copper tripeptide gel, its vehicle and no treatment for 13 days.
- Population
- Twenty-four adult male Sprague-Dawley rats; no dogs were studied.
- Intervention
- Topical tripeptide-copper gel.
- What was measured
- Wound area and concentrations of TNF-alpha, MMP-2 and MMP-9.
- What the paper reported
- The authors reported faster wound-area reduction and lower measured inflammatory and matrix-remodelling markers in the treated rat wounds.
- Important limitations
- Rodent-only acute ischemic wounds; this does not demonstrate a canine or whole-body aging effect.
- Non-canine null-result studyPubMed PMID 23744835
Effects of Topical Copper Tripeptide Complex on Wound Healing in an Irradiated Rat Model
Parker NP, Ardeshirpour F, Schmechel SC, Lassig AA. Otolaryngology–Head and Neck Surgery. 2013;149(3):384–389.
- Study design
- Controlled topical-treatment study in an irradiated skin-flap model.
- Population
- Twenty-three rats: 13 treated and 10 controls; no dogs were studied.
- Intervention
- Topical copper tripeptide gel compared with an ointment control.
- What was measured
- Ischemic area, blood-vessel number and area, caveolin-1 and VEGF staining.
- What the paper reported
- The study found no improvement in vascular measures or VEGF expression and concluded that the treatment did not benefit healing in this model.
- Important limitations
- A short rodent irradiation model, but important counterevidence showing that favorable wound findings have not been consistent across models.
Keep reading
BPC-157
ReadCanine preclinical researchSS-31 / Elamipretide
ReadCanine clinical researchBioactive collagen peptides
ReadAnimal / mechanistic researchThymosin Beta-4
ReadAnimal / mechanistic researchKPV
ReadAnimal / mechanistic researchMOTS-c
ReadEmerging researchSelank & Semax
ReadEmerging researchThymosin Alpha-1
Read